Clinical Trials in Portugal: How Can we Improve?

Authors

  • Marta Carvalho Departamento de Ciências Farmacológicas. Faculdade de Farmácia. Universidade de Lisboa. Lisboa. Instituto de Saúde Baseada na Evidência. Faculdade de Farmácia. Universidade de Lisboa. Lisboa.
  • Rita Cunha de Eça Departamento de Psicologia Clínica e da Saúde. Hospital da Luz. Lisboa.
  • Isabel Gomes Serviços Farmacêuticos. Centro Hospitalar e Universitário de Coimbra. Coimbra.
  • Mónica Gonçalves Centro Clínico Académico de Braga. Faculdade de Medicina. Universidade do Minho. Braga.
  • Ana Lopes Centro de Investigação Clínica. Centro Académico de Medicina de Lisboa. Centro Hospitalar e Universitário Lisboa Norte. Lisboa.
  • Dina Lopes Departamento de Ensino, Formação e Investigação. Centro Hospitalar Universitário do Porto. Porto.
  • Joana Maia Unidade de Investigação Clínica. Instituto Português de Oncologia. Porto.
  • Ana Marta Oliveira Departamento de Ensaios Clínicos. Centro Hospitalar e Universitário de São João. Porto.
  • Ana Noronha Departamento de Ensaios Clínicos. CUF Academic and Research Medical Center. Lisboa.
  • Catarina Resende Oliveira Centro de Inovação em Biomedicina e Biotecnologia. Faculdade de Medicina. Universidade de Coimbra. Coimbra.

DOI:

https://doi.org/10.20344/amp.15155

Keywords:

Clinical Trials as Topic, Portugal

Abstract

N/a.

Downloads

Download data is not yet available.

Downloads

Published

2021-02-01

How to Cite

1.
Carvalho M, Cunha de Eça R, Gomes I, Gonçalves M, Lopes A, Lopes D, Maia J, Oliveira AM, Noronha A, Oliveira CR. Clinical Trials in Portugal: How Can we Improve?. Acta Med Port [Internet]. 2021 Feb. 1 [cited 2024 Nov. 22];34(2):80-3. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/15155

Issue

Vol. 34 No. 2 (2021): February

Section

Perspective

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC